Table 2. Characteristics of the cohort stratified by residence in a rural/remote or an urban location.
Variable | Rural/Remote n = 344 | Urban n = 342 | p |
---|---|---|---|
Age at the end of the study | 35 (24–50) | 34 (22–50) | 0.23 |
Age at RHD diagnosis | 29 (18–45) | 28 (16–44) | 0.16 |
Female | 224 (65.1%) | 234 (68.4%) | 0.36 |
Indigenous Australian | 333 (96.8%) | 289 (84.5%) | <0.0001 |
Severe disease | 76 (22.1%) | 101 (29.5%) | 0.03 |
Hospitalisations/person | 5 (2–9) | 5 (3–12) | 0.11 |
RHD-related hospitalisations | 104 (30.2%) | 145 (42.4%) | 0.001 |
Valve surgery or valvuloplasty | 42 (12.2%) | 77 (22.5%) | <0.0001 |
Died | 17 (4.9%) | 22 (6.4%) | 0.40 |
Age at death | 55 (30–70) | 61 (43–71) | 0.60 |
Adherence | 45 (28–62) | 38 (19–53) | 0.02 |
Good adherence | 38/139 (27%) | 35/154 (22.7%) | 0.36 |
Number of echocardiograms | 5 (3–9) | 5 (3–8) | 0.32 |
RHD progression on serial echocardiograms | 66/319 (20.7%) | 65/310 (21.0%) | 0.93 |
Specialist review | 333 (96.8%) | 310 (90.6%) | 0.001 |
Dental review | 134 (39.0%) | 55/342 (16.1%) | <0.0001 |
All numbers are median (interquartile range) or the absolute number (%)